drugset / Trial / NCT03923361
Neural and Antidepressant Effects of Propofol (Phase 2)
NaSingle-groupOpen-labelTreatment
Summary
Moderate-intensity propofol treatments will be administered to participants who are non-responders at the end of Phase 1.
Timeline
- Start
- 2019-04-16
- Primary completion
- 2024-03
- Completion
- 2024-07
Outcome
Outcome not reported
Stopped: “Change in study design based on phase 1 data collection; patient burden was not feasible”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propofol | Small molecule | — | — |
Indications
No indication recorded.